Gemcitabine-Cisplatin Plus Envafolimab in Resectable Biliary Tract Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Gemcitabine-Cisplatin Plus Envafolimab in Resectable Biliary Tract Malignancies	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract cancer, biliary tract disorder, neoplasm	Not yet recruiting	Phase 2	2026-05-20		NCT07599995

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sir Run Run Shaw Hospital	117

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials